Winston Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Mar '10 Mar 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006
Net Income	-2.34	-2.66	-5.14	-2.38	-1.37
Depreciation & Amortization	0.01	0.01	0.01	0.01	0.02
Stock-Based Compensation	0.13	0.09	-	0.17	0.01
Change in Accounts Receivable	-0.02	0.02	0.01	0.02	-0.05
Change in Accounts Payable	0.09	-0.33	0.55	0.22	0.05
Change in Unearned Revenue	-1.27	-1.27	1.58	-	-
Change in Other Net Operating Assets	-0.12	-0.06	-0.08	0.09	-0.07
Operating Cash Flow	-3.54	-4.2	-3.06	-1.87	-2.03
Capital Expenditures	-	-0	-0.01	-	-0.01
Cash Acquisitions	-	-	-	-0.01	-
Divestitures	-	-	-	-	0.68
Sale (Purchase) of Intangibles	-0	0	-0	-	-0.03
Investing Cash Flow	-0	0	-0.02	-0.01	0.64
Issuance of Common Stock	0.05	0.13	-	0.47	-
Repurchase of Common Stock	-	-	-	-0.23	-
Other Financing Activities	-	-	0.23	-	-
Financing Cash Flow	0.05	0.13	4.22	5.05	-
Net Cash Flow	-3.49	-4.06	1.15	3.17	-1.39
Free Cash Flow	-3.54	-4.2	-3.08	-1.87	-2.04
Free Cash Flow Margin	-258.35%	-301.12%	-679.90%	-234.00%	-693.62%
Free Cash Flow Per Share	-0.05	-0.07	-0.06	-0.03	-0.65
Levered Free Cash Flow	-2.71	-2.94	-1.52	-1.09	-
Unlevered Free Cash Flow	-2.71	-2.94	-1.52	-1.09	-
Change in Working Capital	-1.35	-1.65	2.07	0.34	-0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.